High resolution brain SPECT imaging in a clinical substance abuse practice.
Brain SPECT imaging is a nuclear medicine study that uses isotopes bound to neurospecific pharmaceuticals to evaluate regional cerebral blood flow (rCBF) and indirectly metabolic activity. With current available technology and knowledge SPECT has the potential to add important clinical information to benefit patient care in many different areas of a substance abuse practice. This article explores the clinical controversies and limitations of brain SPECT, plus seven ways it has the potential to be immediately useful in clinical substance abuse practice, including: adding valuable information to the prevention, evaluation, and treatment of substance abusers; helping clinicians ask better questions; helping them in making more complete diagnoses and preventing mistakes; evaluating underlying brain system pathology in individual patients; decreasing stigma and increasing compliance; visualizing effectiveness via follow-up evaluations; and encouraging the exploration of innovative and alternative treatments.
Amen
Daniel G
DG
Amen Clinics Inc., 4019 Westerly Place, Suite 100, Newport Beach, CA, USA.
D001921:Brain / Q000000981:diagnostic imaging*; D001931:Brain Mapping; D002560:Cerebrovascular Circulation / Q000502:physiology; D006801:Humans; D019966:Substance-Related Disorders / Q000000981:diagnostic imaging / Q000473:pathology*; D015899:Tomography, Emission-Computed, Single-Photon